ouabain has been researched along with 1-methyl-4-phenylpyridinium in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| de Vries, JB; Hofsteede, RM; Tuntler, J; Westerink, BH | 1 |
| Heavens, RP; McBride, CS; Sirinathsinghji, DJ | 1 |
| Pifl, C; Schloss, P; Scholze, P; Singer, EA; Sitte, HH | 1 |
| Azevedo, I; Calhau, C; Martel, F; Soares-da-Silva, P | 1 |
| Obata, T | 1 |
6 other study(ies) available for ouabain and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Calcium; Corpus Striatum; Dialysis; Dopamine; Glutamates; Glutamic Acid; Haloperidol; Magnesium; Male; Nomifensine; Ouabain; Piperazines; Potassium; Pyridinium Compounds; Rats; Rats, Inbred Strains; Tetrodotoxin | 1989 |
Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Benztropine; Calcium; Corpus Striatum; Dopamine; Kinetics; Male; Neurotoxins; Ouabain; Perfusion; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reference Values; Sodium | 1988 |
Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Carrier Proteins; Cell Line; Enzyme Inhibitors; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Ouabain; p-Chloroamphetamine; Perfusion; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Sodium-Potassium-Exchanging ATPase; Transfection | 2000 |
Transport of [3H]MPP+ in an immortalized rat brain microvessel endothelial cell line (RBE 4).
Topics: 1-Methyl-4-phenylpyridinium; 2,4-Dichlorophenoxyacetic Acid; Amiloride; Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Cations; Cell Line; Dose-Response Relationship, Drug; Endothelium, Vascular; Energy Metabolism; Epithelial Cells; Hydrogen-Ion Concentration; Kinetics; Membrane Potentials; Ouabain; Rats; Sodium; Time Factors; Tritium | 2001 |
Diltiazem, a L-type calcium channel antagonist, suppresses ouabain-enhanced dopamine efflux by 1-methyl-4-phenylpyridinium ion (MPP+) in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Corpus Striatum; Diltiazem; Dopamine; Male; Ouabain; Rats; Rats, Wistar | 2006 |